The Food and Drug Administration has approved a new drug for adults with relapsing forms of Multiple Sclerosis, or MS.
Patients taking the new drug, called Tecfidera, experienced fewer relapses and a delay in progression of the disease. MS is an autoimmune disease that disrupts communication between the brain and other parts of the body.
Patients experience muscle weakness and difficulty with coordination and balance. The symptoms get progressively worse with time, and currently there is no cure.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.